Atlas Trials

The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Clinical trial NCT01227213 · COMPLETED

Trial details

NCT number
NCT01227213
Sponsor
Radboud University Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
HypertensionRenal FunctionInsulin SensitivityRenal Cell Carcinoma
Start date
2010-11-01
Primary completion
2013-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.